Skip to content

Is the pulsed dye laser an effective adjuvant to topical therapy for psoriatic plaques?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN28336586
Enrollment
20
Registered
2006-09-29
Start date
2005-09-14
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis Skin and Connective Tissue Diseases Psoriasis

Interventions

Aim to recruit 20 patients. Informed consent will be obtained. Two symmetrical, similar plaques will be selected by the investigator and randomly allocated to either topical therapy alone, or topica

Sponsors

Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 20 patients with chronic plaque psoriasis, who are on topical treatment only and have symmetrical plaques on legs between 2 and 5 cm in diameter.

Exclusion criteria

Exclusion criteria: 1. Patients under 18 or over 80 years of age 2. Patients who have had systemic or ultraviolet light therapy within past 4 weeks 3. Patients who are unable to attend the laser unit on the six occasions needed

Design outcomes

Primary

MeasureTime frame
Pulsed dye laser treatments when used three times over three months with standard topical therapy effectively prevents recurrence of psoriatic plaques when compared to standard topical therapy alone.

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026